medical guideline

首页 肿瘤学指南 淋巴瘤 详情

Tisagenlecleucel for Treating Relapsed Or Refractory Diffuse Large B-cell Lymphoma after 2 Or More Systemic Therapies

原文:2019年 发布于 National Institute for Health and Care Excellence 浏览量:289 原文链接

作者: National Institute for Health and Care Excellence

归属分类: 所属人体系统: 循环 | 分类: 淋巴瘤

关键词: Lymphoma relapse refractory Diffuse Tisagenlecleucel

指南简介